Publications by authors named "Peter Scanlon"

Claim this Profile
W
What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?
Kathryn Willis, Royce Shakespeare, Lakshmi Chandrasekaran, Umar Chaudhry, Charlotte Wahlich, Peter Scanlon

Diabet Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
Adam J Buckley, Garry D Tan, Marta Gruszka-Goh, Peter H Scanlon, Imran Ansari

Diabetologia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study.
Adam J Buckley, Garry D Tan, Marta Gruszka-Goh, Peter H Scanlon, Imran Ansari

Diabetologia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A thematic analysis of patients' experiences of receiving treatment for Neovascular age-related macular degeneration (nAMD).
Julie Hapeshi, Samantha Hughes, Martin McKibbin, Peter H Scanlon

Eye (Lond)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating evidence to support the role of AI in diabetic eye screening: considerations from the UK National Screening Committee.
Trystan Macdonald, Zhivko Zhelev, Xiaoxuan Liu, Christopher Hyde, Jiri Fajtl, Peter Scanlon

Lancet Digit Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 1.
Peter H Scanlon, Marta Gruszka-Goh, Ushna Javed, Anthony Vukic, Julie Hapeshi

Eye (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 2.
Peter H Scanlon, Marta Gruszka-Goh, Ushna Javed, Anthony Vukic, Julie Hapeshi

Eye (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study.
Amudha Aravindhan, Eva K Fenwick, Aurora Wing Dan Chan, Ryan Eyn Kidd Man, Ngiap Chuan Tan, Peter Scanlon

BMC Public Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration.
Rebecca Jones, Irene M Stratton, Peter H Scanlon, Sofia Theodoropoulou

Eye (Lond)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration.
Rebecca Jones, Irene M Stratton, Peter H Scanlon, Sofia Theodoropoulou

Eye (Lond)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes.
Sobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks, Peter Scanlon

Eye (Lond)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.
Sobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks, Peter Scanlon

Eye (Lond)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study.
Cristina Hernández, Olga Simó-Servat, Massimo Porta, Jakob Grauslund, Simon P Harding, Peter Scanlon

Acta Diabetol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort.
John J Smith, David M Wright, Irene M Stratton, Peter Henry Scanlon, Noemi Lois

Br J Ophthalmol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the screening of risk factors in diabetic retinopathy.
Peter H Scanlon

Expert Rev Endocrinol Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Is Continued Vision Loss Still a Problem in Some Patients With Diabetic Retinopathy, Despite Treatment?
Susan B Bressler, Peter H Scanlon, Elizabeth Pearce

JAMA Ophthalmol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire.
Peter H Scanlon, Clareece R Nevill, Irene M Stratton, Sonia S Maruti, Elvira L Massó-González

Acta Ophthalmol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease.
Stela Vujosevic, José Cunha-Vaz, João Figueira, Anat Löwenstein, Edoardo Midena, Peter Henry Scanlon

Ophthalmic Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre.
Peter H Scanlon, Charlotte F E Norridge, Paul H J Donachie, Quresh Mohamed

Eye (Lond)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes.
Sobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks, Peter Scanlon

Eye (Lond)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study.
Sobha Sivaprasad, Katie Banister, Augusto Azuro-Blanco, Beatriz Goulao, Jonathan A Cook, Peter Scanlon

Ophthalmology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis.
Fangyao Tang, Xi Wang, An-Ran Ran, Carmen K M Chan, Mary Ho, Peter H Scanlon

Diabetes Care· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.
Noemi Lois, Jonathan Cook, Ariel Wang, Stephen Aldington, Hema Mistry, Peter Scanlon

Health Technol Assess· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.
Peter H Scanlon

Acta Diabetol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis